Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041738 | SCV000065434 | benign | not specified | 2010-06-17 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000041738 | SCV000231900 | benign | not specified | 2014-07-22 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000041738 | SCV001477198 | benign | not specified | 2020-07-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000087006 | SCV001717473 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000087006 | SCV001914907 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450772 | SCV004181889 | benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001826590 | SCV004181890 | benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000087006 | SCV005287603 | benign | not provided | criteria provided, single submitter | not provided | ||
NEI Ophthalmic Genomics Laboratory, |
RCV000087006 | SCV000119259 | not provided | not provided | no assertion provided | not provided | ||
Natera, |
RCV001826590 | SCV002088269 | likely benign | Usher syndrome type 2A | 2019-11-27 | no assertion criteria provided | clinical testing |